Predictors of Refractory Macular Edema after Branch Retinal Vein Occlusion following Intravitreal Bevacizumab.


PURPOSE To evaluate the predictors of refractory macular edema (ME) that develops despite multiple bevacizumab injections in patients with branch retinal vein occlusion (BRVO). METHODS A total of 107 patients who followed at least 2 years were assigned to 2 groups: a refractory group (n = 56) and a responsive group (n = 51). Baseline characteristics… (More)
DOI: 10.1097/IAE.0000000000001674


5 Figures and Tables

Slides referencing similar topics